Zhejiang Hisoar Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in China and internationally. It operates through Pharmaceutical Industry, Dye Industry, and Others segments. The company offers antibiotics, cardiovascular drugs, hypoglycemic agents, formulations, and fine chemicals. It also provides dyes and pigment intermediates; environmental protection-related equipment; medical chemical supplies and appliances; and other chemical intermediates. In addition, the company engages in technology research and development; trading; hazardous waste treatment; equity investment; technical consulting and other consulting services; and venture capital activities. It exports its products to approximately 30 countries, including Europe, America, and Asia. Zhejiang Hisoar Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Taizhou, China.
Research context
Zhejiang Hisoar Pharmaceutical Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Zhejiang Hisoar Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 8.6% below its 200 day moving average.
From a valuation standpoint, the stock is 32.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.5.
Zhejiang Hisoar Pharmaceutical Co., Ltd's total revenue rose by 0.1% to $644M since the same quarter in the previous year.
Its net income has dropped by 50.4% to $96M since the same quarter in the previous year.
Finally, its free cash flow grew by 64.0% to $155M since the same quarter in the previous year.
Based on the above factors, Zhejiang Hisoar Pharmaceutical Co., Ltd gets an overall score of 3/5.